TGFBR2 and ductal breast carcinoma in situ: We thus extracted the injected DCIS cells, designated DCIScnt2cy or DCISCAF2cy, from the developing subcutaneous tumor xenografts admixed with control fibroblasts (expressing GFP) or CAFs (expressing GFP or the TβRII ecto), respectively, in mice (Fig 7B).